US Stock MarketDetailed Quotes

DRUG Bright Minds Biosciences

Watchlist

0.9900
-0.0559-5.34%

Close May 3 16:00 ET

4.42MMarket Cap-765P/E (TTM)

Bright Minds Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Dec 31, 2023

(FY)Sep 30, 2023

(Q4)Sep 30, 2023

(Q3)Jun 30, 2023

(Q2)Mar 31, 2023

(Q1)Dec 31, 2022

(FY)Sep 30, 2022

(Q4)Sep 30, 2022

(Q3)Jun 30, 2022

(Q2)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

69.14%-822.09K

48.30%-7.02M

43.74%-1.2M

42.33%-1.65M

58.51%-1.51M

46.20%-2.66M

-85.63%-13.59M

10.92%-2.13M

3.72%-2.86M

-159.01%-3.65M

Net income from continuing operations

27.88%-1.68M

50.74%-7.37M

48.40%-1.53M

45.14%-1.46M

54.31%-2.05M

51.93%-2.34M

-72.99%-14.96M

-3.28%-2.96M

24.77%-2.66M

-183.43%-4.49M

Operating gains losses

500.01%42.3K

117.52%45.35K

417.62%163.44K

-467.93%-130.47K

-23.72%5.33K

103.68%7.05K

-15.66%-258.82K

66.21%-51.46K

69.49%-22.97K

161.84%6.99K

Depreciation and amortization

0.01%18.11K

1,100.10%72.45K

200.02%18.11K

--18.11K

--6.04K

--0

Other non cash items

-50.93%2.97K

-32.88%19.75K

74.23%3.79K

--4.58K

--5.33K

--6.06K

-92.02%29.42K

--2.17K

----

Change In working capital

168.74%579.85K

-230.05%-941.72K

-130.26%-255.36K

35.77%-322K

-11.94%479.25K

-419.24%-843.6K

136.58%724.13K

233.34%843.75K

-7,621.08%-501.36K

779.54%544.2K

-Change in receivables

-108.35%-8.06K

360.33%118.8K

173.02%66.7K

-162.80%-70.31K

197.00%25.91K

344.04%96.5K

58.57%-45.63K

-184.01%-91.34K

371.52%111.97K

26.30%-26.71K

-Change in prepaid assets

-169.82%-4.38K

3,519.30%136.74K

235.54%114.04K

662.24%37.11K

-136.29%-20.68K

-75.93%6.27K

104.20%3.78K

-109.65%-84.14K

-96.10%4.87K

129.50%57K

-Change in payables and accrued expense

162.58%592.29K

-256.30%-1.2M

-142.79%-436.1K

53.28%-288.8K

-7.76%474.02K

-535.25%-946.38K

51.34%765.99K

213.21%1.02M

-704.66%-618.19K

76.39%513.92K

Cash from discontinued investing activities

Operating cash flow

69.14%-822.09K

48.30%-7.02M

43.74%-1.2M

42.33%-1.65M

58.51%-1.51M

46.20%-2.66M

-85.63%-13.59M

10.92%-2.13M

3.72%-2.86M

-159.01%-3.65M

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

-61.05%878.04K

-57.86%2.19M

-100.43%-21.65K

-279.08%-21.49K

-1,376.13%-21.49K

1,806.39%2.25M

-80.06%5.2M

52,308.82%5.06M

102.20%12K

-99.99%1.68K

Net issuance payments of debt

-2.18%-21.96K

-1,102.35%-86.11K

-187.14%-21.65K

---21.49K

32.84%-21.49K

---21.49K

---7.16K

--24.84K

--0

---32K

Net common stock issuance

-26.08%900K

-69.83%1.22M

--0

--1.22M

-85.46%4.03M

--4.03M

--0

Proceeds from stock option exercised by employees

--0

-44.87%1.09M

--0

817.78%1.09M

1,576.70%1.97M

19,050.48%1.84M

-89.75%12K

--0

Net other financing activities

----

96.63%-26.98K

--0

---26.98K

55.72%-799.98K

---833.66K

--0

----

Cash from discontinued financing activities

Financing cash flow

-61.05%878.04K

-57.86%2.19M

-100.43%-21.65K

-279.08%-21.49K

-1,376.13%-21.49K

1,806.39%2.25M

-80.06%5.2M

52,308.82%5.06M

102.20%12K

-99.99%1.68K

Net cash flow

Beginning cash position

-41.97%6.75M

-41.15%11.63M

-5.90%8.13M

-15.66%9.67M

-25.84%11.21M

-41.15%11.63M

2,370.22%19.76M

-60.74%8.64M

-54.94%11.47M

616.87%15.12M

Current changes in cash

113.67%55.96K

42.38%-4.83M

-141.53%-1.22M

41.33%-1.67M

57.90%-1.53M

91.53%-409.36K

-144.78%-8.39M

222.36%2.94M

18.99%-2.85M

-115.62%-3.64M

Effect of exchange rate changes

-500.01%-42.3K

-117.52%-45.35K

-417.62%-163.44K

467.93%130.47K

23.72%-5.33K

-103.68%-7.05K

15.66%258.82K

-66.21%51.46K

-69.49%22.97K

-161.84%-6.99K

End cash Position

-39.69%6.76M

-41.97%6.75M

-5.90%8.13M

-15.66%9.67M

-25.84%11.21M

-41.15%11.63M

-60.74%8.64M

-54.94%11.47M

Free cash flow

69.14%-822.09K

48.30%-7.02M

43.74%-1.2M

42.33%-1.65M

58.51%-1.51M

46.20%-2.66M

-85.63%-13.59M

10.92%-2.13M

3.72%-2.86M

-159.01%-3.65M

Currency Unit

CAD

Audit Opinions

Unqualified Opinion

	(Q1)Dec 31, 2023	(FY)Sep 30, 2023	(Q4)Sep 30, 2023	(Q3)Jun 30, 2023	(Q2)Mar 31, 2023	(Q1)Dec 31, 2022	(FY)Sep 30, 2022	(Q4)Sep 30, 2022	(Q3)Jun 30, 2022	(Q2)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	69.14%-822.09K	48.30%-7.02M	43.74%-1.2M	42.33%-1.65M	58.51%-1.51M	46.20%-2.66M	-85.63%-13.59M	10.92%-2.13M	3.72%-2.86M	-159.01%-3.65M
Net income from continuing operations	27.88%-1.68M	50.74%-7.37M	48.40%-1.53M	45.14%-1.46M	54.31%-2.05M	51.93%-2.34M	-72.99%-14.96M	-3.28%-2.96M	24.77%-2.66M	-183.43%-4.49M
Operating gains losses	500.01%42.3K	117.52%45.35K	417.62%163.44K	-467.93%-130.47K	-23.72%5.33K	103.68%7.05K	-15.66%-258.82K	66.21%-51.46K	69.49%-22.97K	161.84%6.99K
Depreciation and amortization	0.01%18.11K	1,100.10%72.45K	200.02%18.11K	--18.11K	--18.11K	--18.11K	--6.04K	--6.04K	--0	--0
Other non cash items	-50.93%2.97K	-32.88%19.75K	74.23%3.79K	--4.58K	--5.33K	--6.06K	-92.02%29.42K	--2.17K	----	----
Change In working capital	168.74%579.85K	-230.05%-941.72K	-130.26%-255.36K	35.77%-322K	-11.94%479.25K	-419.24%-843.6K	136.58%724.13K	233.34%843.75K	-7,621.08%-501.36K	779.54%544.2K
-Change in receivables	-108.35%-8.06K	360.33%118.8K	173.02%66.7K	-162.80%-70.31K	197.00%25.91K	344.04%96.5K	58.57%-45.63K	-184.01%-91.34K	371.52%111.97K	26.30%-26.71K
-Change in prepaid assets	-169.82%-4.38K	3,519.30%136.74K	235.54%114.04K	662.24%37.11K	-136.29%-20.68K	-75.93%6.27K	104.20%3.78K	-109.65%-84.14K	-96.10%4.87K	129.50%57K
-Change in payables and accrued expense	162.58%592.29K	-256.30%-1.2M	-142.79%-436.1K	53.28%-288.8K	-7.76%474.02K	-535.25%-946.38K	51.34%765.99K	213.21%1.02M	-704.66%-618.19K	76.39%513.92K
Cash from discontinued investing activities
Operating cash flow	69.14%-822.09K	48.30%-7.02M	43.74%-1.2M	42.33%-1.65M	58.51%-1.51M	46.20%-2.66M	-85.63%-13.59M	10.92%-2.13M	3.72%-2.86M	-159.01%-3.65M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities	-61.05%878.04K	-57.86%2.19M	-100.43%-21.65K	-279.08%-21.49K	-1,376.13%-21.49K	1,806.39%2.25M	-80.06%5.2M	52,308.82%5.06M	102.20%12K	-99.99%1.68K
Net issuance payments of debt	-2.18%-21.96K	-1,102.35%-86.11K	-187.14%-21.65K	---21.49K	32.84%-21.49K	---21.49K	---7.16K	--24.84K	--0	---32K
Net common stock issuance	-26.08%900K	-69.83%1.22M	--0	--0	--0	--1.22M	-85.46%4.03M	--4.03M	--0	--0
Proceeds from stock option exercised by employees	--0	-44.87%1.09M	--0	--0	--0	817.78%1.09M	1,576.70%1.97M	19,050.48%1.84M	-89.75%12K	--0
Net other financing activities	----	96.63%-26.98K	--0	--0	--0	---26.98K	55.72%-799.98K	---833.66K	--0	----
Cash from discontinued financing activities
Financing cash flow	-61.05%878.04K	-57.86%2.19M	-100.43%-21.65K	-279.08%-21.49K	-1,376.13%-21.49K	1,806.39%2.25M	-80.06%5.2M	52,308.82%5.06M	102.20%12K	-99.99%1.68K
Net cash flow
Beginning cash position	-41.97%6.75M	-41.15%11.63M	-5.90%8.13M	-15.66%9.67M	-25.84%11.21M	-41.15%11.63M	2,370.22%19.76M	-60.74%8.64M	-54.94%11.47M	616.87%15.12M
Current changes in cash	113.67%55.96K	42.38%-4.83M	-141.53%-1.22M	41.33%-1.67M	57.90%-1.53M	91.53%-409.36K	-144.78%-8.39M	222.36%2.94M	18.99%-2.85M	-115.62%-3.64M
Effect of exchange rate changes	-500.01%-42.3K	-117.52%-45.35K	-417.62%-163.44K	467.93%130.47K	23.72%-5.33K	-103.68%-7.05K	15.66%258.82K	-66.21%51.46K	-69.49%22.97K	-161.84%-6.99K
End cash Position	-39.69%6.76M	-41.97%6.75M	-41.97%6.75M	-5.90%8.13M	-15.66%9.67M	-25.84%11.21M	-41.15%11.63M	-41.15%11.63M	-60.74%8.64M	-54.94%11.47M
Free cash flow	69.14%-822.09K	48.30%-7.02M	43.74%-1.2M	42.33%-1.65M	58.51%-1.51M	46.20%-2.66M	-85.63%-13.59M	10.92%-2.13M	3.72%-2.86M	-159.01%-3.65M
Currency Unit	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall